Therapix Biosciences' Board Chairman, Ascher Shmulewitz, Appointed as Interim Chief Executive Officer

TEL AVIV, Israel, Nov. 2, 2017 -- (Healthcare Sales & Marketing Network) -- Therapix Biosciences Ltd. (NASDAQ: TRPX) ("Therapix" or the "Company"), a specialty clinical-stage pharmaceutical company developing cannabinoid-based treatmen... Biopharmaceuticals, Neurology, Personnel Therapix Biosciences, dronabinol, cannabinoid, Tourette syndrome
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news